The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tskhaĭ V.B.

Krasnoiarskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. prof. V.F. Voĭno-Iasenetskogo

Grebennikova E.K.

V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia, 660022

Yametov P.K.

V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia, 660022

Kel’berg V.G.

V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia, 660022

Successful metroplastic operation after medical therapy with selective modulators of progesteron receptors in a patient with prolifera­ting myoma and adenomyosis (case report)

Authors:

Tskhaĭ V.B., Grebennikova E.K., Yametov P.K., Kel’berg V.G.

More about the authors

Journal: Russian Journal of Human Reproduction. 2016;22(2): 94‑98

Read: 2296 times


To cite this article:

Tskhaĭ VB, Grebennikova EK, Yametov PK, Kel’berg VG. Successful metroplastic operation after medical therapy with selective modulators of progesteron receptors in a patient with prolifera­ting myoma and adenomyosis (case report). Russian Journal of Human Reproduction. 2016;22(2):94‑98. (In Russ.)
https://doi.org/10.17116/repro201622294-98

References:

  1. Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(9):924-931.  doi: 10.1055/s-0033-1350840.
  2. Levy G, Dehaene A, Laurent N, Lernout M, Collinet P, Lucot JP, et al. An update on adenomyosis. Diagn Interv Imaging. 2013;94(1):3-25.  doi: 10.1016/j.diii.2012.10.012.
  3. Ashrafyan LA, Kiselev VI, Muizhnek EL. Patogeneticheskaya profilaktika raka reproduktivnykh organov. M.: Molodaya Gvardiya. 2009. (In Russ.).
  4. Grebennikova EK, Tskhy VB, Medvedeva NN. Constitutional features of women with hyperplastic diseases of the uterus. Sibirskoe meditsinskoe obozrenie. 2012;4:37-40. (In Russ.).
  5. Sivova EN, Pachov AI, Bukreev AV, Fokina AP. Some questions of etiology and pathogenesis of endometrial proliferative processes. Sibirskoe meditsinskoe obozrenie. 2015;1:16-22. (In Russ.).
  6. Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010;25(5):1177-1182. doi: 10.1093/humrep/deq034.
  7. Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et. al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409-420.  doi: 10.1056/NEJMoa1103182.
  8. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001;16(11):2418-2421.
  9. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update. 2012;18(4):374-392.  doi: 10.1093/humupd/dms006.
  10. Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293-298.
  11. Lebedev VA, Pashkov VM. Treatment of chronic iron deficiency anemia at patients with myoma and adenomyosis. Trudnyi patsient. 2008;10(6):27-30. (In Russ.).
  12. Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN). Fertil Steril. 2009;91(1):201-206.  doi: 10.1016/j.fertnstert.2007.11.025.
  13. Healey S, Buzaqlo K, Seti L, Valenti D, Tulandi T. Ovarian function after uterine artery embolization and hysterectomy. J Am Assoc Gynecol Laparosc. 2004;11(3):348-352.
  14. Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Hum Reprod. 2014;29(3):480-489.  doi: 10.1093/humrep/det467.
  15. Korennaya VV, Podzolkova NM. Ulipristal acetate in the treatment of myoma. Ginekologiya. 2013;15(6):20-24. (In Russ.).
  16. Whitaker LH, Williams AR, Critchley HO. Selective progesterone receptor modulators. Curr Opin Obstet Gynecol. 2014;26(4):237-242.  doi: 10.1097/GCO.0000000000000082.
  17. Adamian LV, Zairat'iants OV, Tikhomirov AL, Manukhin IB, Opalenov KV, Kazenashev VV, Alieva TD. Antiproliferative and proapoptotic effects of the selective progesterone receptor modulator ulipristal on uterine leiomyoma in vivo. Problemy reproduktsii. 2014;3:41-44. (In Russ.).
  18. Levakov SA, Zairat'yants OV, Borovkova EI. Effectivity and safety of therapy by inhibitors of progesterone receptor at patients with simple and proliferating myoma. Akusherstvo i ginekologiya. 2015;3:94-99. (In Russ.).
  19. Tikhomirov AL, Kazenashev VV. Ulipristal acetate — new opportunities in the treatment of uterine leiomyoma. Akusherstvo i ginekologiya. 2013;9:97-100. (In Russ.).
  20. Donnez J, Donnez O, Dolmans MM. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril. 2014;102(3): 640-648.  doi: 10.1016/j.fertnstert.2014.06.041.
  21. Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online. 2011;22(1):94-99.  doi: 10.1016/j.rbmo.2010.09.014.
  22. Kiselev VI, Sidorova IS, Unanyan AL, Muizhnek EL. Giperplasticheskie protsessy organov zhenskoi reproduktivnoi sistemy: teoriya i praktika. M.: Medpraktika-M. 2011. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.